Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 66

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 66
---
 termination of our engagement
of the placement agent, subject to an exception.

Other Relationships

From time to time, the placement agent may provide in the future, various
advisory, investment and commercial banking and other services to us in the ordinary course of business, for which it may receive customary
fees and commissions. The placement agent acted as our placement agent in connection with the private placement we consummated in September
2024 and the registered direct offerings we consummated in January 2025 and February 2025, for which it received compensation. Except
as disclosed in this prospectus, we have no present arrangements with the placement agent for any further services. An associated person
of the placement agent has agreed to purchase in this offering, on the same terms and conditions, 131,579 shares of common stock, Series
A-1 warrants to purchase up to 131,579 shares of common stock and Series A-2 warrants to purchase up to 131,579 shares of common stock
for a total purchase price of $250,000.10.

Determination of Offering Price

The combined offering
price per share and accompanying Warrants and the combined offering price per Pre-Funded Warrants and accompanying Warrants we are offering
and the exercise prices and other terms of the Warrants were negotiated between us and the investors, in consultation with the placement
agent based on the trading of our common stock prior to this offering, among other things. Other factors considered in determining the
offering prices of the securities we are offering and the exercise prices and other terms of the Warrants include the history and prospects
of our company, the stage of development of our business, our business plans for the future and the extent to which they have been implemented,
an assessment of our management, general conditions of the securities markets at the time of the offering and such other factors as were
deemed relevant.

<div align='center'>35</div>

Lock-up Agreements

We and each of our executive
officers, directors and holders of 5% or greater of our outstanding shares of common stock have agreed with the placement agent to be
subject to a lock-up period of 90 days following the date of closing of the offering pursuant to this prospectus. This means that, during
the applicable lock-up period, we and such persons may not offer for sale, contract to sell, sell, distribute, grant any option, right
or warrant to purchase, pledge, hypothecate or otherwise dispose of